BNGO
Bionano Genomics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BNGO
Bionano Genomics, Inc.
A company that develops saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection
Life Science Tools and Services
08/16/2007
09/21/2018
NASDAQ Stock Exchange
98
12-31
Common stock
9540 Towne Centre Drive
, Suite 100
, San Diego
, CA 92121
--
Bionano Genomics, Inc., was incorporated in Delaware on August 16, 2007. The company is a life science instrument company in the field of genome analysis. The company develops and markets the Saphyr system, an ultra-sensitive and ultra-specific structural variation detection platform that enables researchers and clinicians to accelerate the search for new diagnostic and therapeutic targets and simplify the study of chromosomal changes, known as cytogenetics. The Bionano Genomics Saphyr system includes instruments, chip consumables, reagents and a set of data analysis tools.
Earnings Call
Q2/2025
Estimate EPS-2.93
Actual EPS-1.99
Estimate Revenue6.56M
Actual Revenue6.73M
Bionano Genomics Q2 2025: Key Contradictions in Strategy, Revenue Growth, and System Utilization
Aug 15,2025 04:45
Earnings Decrypt
Earnings Decrypt
Q1/2025
Estimate EPS--
Actual EPS-1.15
Estimate Revenue6.25M
Actual Revenue6.46M
Bionano Genomics Q1 2025: Navigating Contradictions in Customer Strategy, Gross Margins, and Product Launches
May 20,2025 07:59
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
BNGO has released its 2025 Q3 earnings. EPS was reported at -2.08, versus the expected -2.34, beating expectations. The chart below visualizes how BNGO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BNGO has released its 2025 Q3 earnings report, with revenue of 7.37M, reflecting a YoY change of 21.31%, and net profit of -8.50M, showing a YoY change of 80.78%. The Sankey diagram below clearly presents BNGO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
